Control is only possible through mass testing. Testing helps us with 2 stages of controlling the pandemic, the first is diagnosis of the infected patients via virus specific molecular tests and the second is identifying recovered patients via immunochromatography (rapid test). While getting ready for the post Covid-19 state we understand the importance of being technologically prepared for post corona stage and the future pandemics. That’s why we started develop Sars-Cov-2 specific diagnostic rapid tests and virus specific anti-human antibody/antigen rapid tests and a standardized screening device.

GNZ – RH is the first genetic fetal RH screening test in Turkey, approved by Ministry of Health and registered to the UTS (Product Tracking System).

GNZ-BRC is the first custom panel breast cancer genetic screening test in Turkey, approved by Ministry of Health and registered to the UTS (Product Tracking System).